IL-33, on the other hand, accelerates Th2-associated cytokine synthesis and upregulates glucose transporter protein 1 (GLUT1) through the IL-33/ST2 pathway to enhance glucose uptake and glycolysis in tumor cells, while promoting growth and metastasis of non-small cell lung cancer (Wang et al., 2016). The gene discussed is IL33; the disease is neoplasm.